Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2014

Aug 14, 2014

30718_dirs_2014-08-14_3f09d57b-22d7-4f09-a6ad-803f585325a8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2014-08-12

Reporting Person: Furlow Brenda S. (SVP - General Counsel)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-12 Stock Option (Right to Buy) $94.35 A 15000 Acquired 2021-08-12 Common Stock (15000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2500 Direct

Footnotes

F1: Includes 2,500 restricted stock units that represent a contingent right to receive one share of Techne Corporation common stock. The restricted stock units vest subject to certain conditions beginning July 1, 2015 and annually thereafter, in a total of three equal installments. Shares will be delivered to the reporting person following vesting.

F2: Vests 3,750 on each of 8/12/15, 8/12/16, 8/12/17, and 8/12/18.